Literature DB >> 20595236

Kif18A is involved in human breast carcinogenesis.

Chunpeng Zhang1, Changjun Zhu, Hongyan Chen, Linwei Li, Liping Guo, Wei Jiang, Shih Hsin Lu.   

Abstract

Microtubule (MT) kinesin motor proteins orchestrate various cellular processes (e.g. mitosis, motility and organelle transportation) and have been implicated in human carcinogenesis. Kif18A, a plus-end directed MT depolymerase kinesin, regulates MT dynamics, chromosome congression and cell division. In this study, we report that Kif18A is overexpressed in human breast cancers and Kif18A overexpression is associated with tumor grade, metastasis and poor survival. Functional analyses reveal that ectopic overexpression of Kif18A results in cell multinucleation, whereas ablation of Kif18A expression significantly inhibits the proliferative capability of breast cancer cells in vitro and in vivo. Inhibition of Kif18A not only affects the critical mitotic function of Kif18A but also decreases cancer cell migration by stabilizing MTs at leading edges and ultimately induces anoikis of cells with inactivation of the phosphatidylinositol 3-kinase-Akt signaling pathway. Together, our results indicate that Kif18A is involved in human breast carcinogenesis and may serve as a potential therapeutic target for human breast cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20595236     DOI: 10.1093/carcin/bgq134

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  50 in total

Review 1.  Targeting mitotic pathways for endocrine-related cancer therapeutics.

Authors:  Shivangi Agarwal; Dileep Varma
Journal:  Endocr Relat Cancer       Date:  2017-06-14       Impact factor: 5.678

Review 2.  Role of genetic and molecular profiling in sarcomas.

Authors:  Scott M Norberg; Sujana Movva
Journal:  Curr Treat Options Oncol       Date:  2015-05

3.  Three-Dimensional Optical Tweezers Tracking Resolves Random Sideward Steps of the Kinesin-8 Kip3.

Authors:  Michael Bugiel; Erik Schäffer
Journal:  Biophys J       Date:  2018-10-02       Impact factor: 4.033

4.  Clinical relevance of cytoskeleton associated proteins for ovarian cancer.

Authors:  Johanna Schiewek; Udo Schumacher; Tobias Lange; Simon A Joosse; Harriet Wikman; Klaus Pantel; Marina Mikhaylova; Matthias Kneussel; Stefan Linder; Barbara Schmalfeldt; Leticia Oliveira-Ferrer; Sabine Windhorst
Journal:  J Cancer Res Clin Oncol       Date:  2018-08-09       Impact factor: 4.553

5.  Clinicopathological relevance of kinesin family member 18A expression in invasive breast cancer.

Authors:  Mai Kasahara; Makoto Nagahara; Tsuyoshi Nakagawa; Toshiaki Ishikawa; Takanobu Sato; Hiroyuki Uetake; Kenichi Sugihara
Journal:  Oncol Lett       Date:  2016-07-07       Impact factor: 2.967

6.  The Kinesin-8 Kip3 Depolymerizes Microtubules with a Collective Force-Dependent Mechanism.

Authors:  Michael Bugiel; Mayank Chugh; Tobias Jörg Jachowski; Erik Schäffer; Anita Jannasch
Journal:  Biophys J       Date:  2020-03-14       Impact factor: 4.033

Review 7.  Kinesins and cancer.

Authors:  Oliver Rath; Frank Kozielski
Journal:  Nat Rev Cancer       Date:  2012-07-24       Impact factor: 60.716

8.  Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance.

Authors:  June X Zou; Zhijian Duan; Junjian Wang; Alex Sokolov; Jianzhen Xu; Christopher Z Chen; Jian Jian Li; Hong-Wu Chen
Journal:  Mol Cancer Res       Date:  2014-01-03       Impact factor: 5.852

9.  Involvement of S100A14 protein in cell invasion by affecting expression and function of matrix metalloproteinase (MMP)-2 via p53-dependent transcriptional regulation.

Authors:  Hongyan Chen; Yi Yuan; Chunpeng Zhang; Aiping Luo; Fang Ding; Jianlin Ma; Shouhui Yang; Yanyan Tian; Tong Tong; Qimin Zhan; Zhihua Liu
Journal:  J Biol Chem       Date:  2012-03-26       Impact factor: 5.157

10.  Elevated expression of KIF18A enhances cell proliferation and predicts poor survival in human clear cell renal carcinoma.

Authors:  Q I Chen; Bin Cao; Ning Nan; Y U Wang; X U Zhai; Youfang Li; Tie Chong
Journal:  Exp Ther Med       Date:  2016-05-11       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.